TECX — Tectonic Therapeutic, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1681087 ·
Last close
$20.08
Market Cap
$392.55M
52W High
$39.53
52W Low
$16.77
ADV30
182,100
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -23,458,000 -21,347,000 243,860,000 234,666,000 14,535,000
Jun 2026 0 — -24,218,000 -22,285,000 237,034,000 227,068,000 13,188,000
Mar 2026 0 — -27,301,000 -25,241,000 246,577,000 236,894,000 16,160,000
Dec 2025 0 — -21,516,000 -19,226,000 261,038,000 253,798,000 9,709,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-72,140,000
Investing CF
$-244,000
Financing CF
$11,931,000
CapEx
$-306,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.57
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-270,263,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-85,416,000
Pretax Income TTM
$-85,456,000
Interest Exp TTM
$40,000
Analysts
9

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -84,036,000 -74,151,000 261,038,000 9,709,000 251,329,000 -60,078,000
Dec 2024 0 -58,015,000 -57,982,000 152,905,000 12,129,000 140,776,000 -59,080,000
Dec 2023 0 -44,648,000 -42,823,000 39,399,000 124,035,000 -84,636,000 -40,681,000
Dec 2022 0 -32,830,000 -32,180,000 47,209,000 92,863,000 -45,654,000 -27,637,000

TTM Snapshot

Revenues TTM
$9,666,000
NetIncome TTM
$-85,787,000
OpCashFlow TTM
—
Assets (Latest)
$237,034,000
Forward EPS
$-4.76

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $25.00 · spot: $21.04 · call volume: 2,039 · put volume: 2,012
Expected Move to 2027-01-15: ±$12.45 (59.17%) — implied range $8.59 – $33.49 · ATM straddle on $20.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ALEC Alector, Inc. $381.13M $2.56 —
IRLA IRulya Therapeutics Inc. $416.85M $38.45 —
CADL Candel Therapeutics, Inc. $423.61M $5.40 —
SLBT SL Science Holding Ltd $356.14M $0.64 —
JSPR Jasper Therapeutics, Inc. $344.06M $10.34 —

News headlines (Yahoo Finance, 1h cache)

Tectonic Therapeutic to Participate in Upcoming Investor Conferences
2026-11-09 13:00 · Yahoo
Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights
2026-11-05 21:01 · Yahoo
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare
2026-09-10 04:55 · Yahoo
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
2026-05-07 20:01 · Yahoo
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
2026-05-01 14:24 · Yahoo
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
2026-04-23 20:01 · Yahoo
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
2026-09-29 12:00 · Yahoo
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
2026-08-06 20:01 · Yahoo
TD Asset Management Inc. Announces TD ETF Distributions
2026-06-17 12:30 · Yahoo
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
2026-06-10 20:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.